307 related articles for article (PubMed ID: 16757256)
1. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P
Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole.
Kartsonis N; DiNubile MJ; Bartizal K; Hicks PS; Ryan D; Sable CA
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):183-7. PubMed ID: 12394797
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
Keating G; Figgitt D
Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin in kidney transplant recipients with refractory invasive candidiasis.
Veroux M; Corona D; Macarone M; Gagliano M; Giuffida G; Veroux P
Nephrol Dial Transplant; 2007 May; 22(5):1487-9. PubMed ID: 17210588
[No Abstract] [Full Text] [Related]
5. Resolution of azole-resistant oesophageal candidiasis in an AIDS patient after treatment with caspofungin.
Smith K; Youle M; Baker B; Ballinger J; Cuthbertson Z; Johnson M
AIDS; 2003 Feb; 17(3):448-9. PubMed ID: 12556703
[No Abstract] [Full Text] [Related]
6. Caspofungin therapy of neonates with invasive candidiasis.
Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients.
Saner F; Gensicke J; Rath P; Fruhauf N; Gu Y; Paul A; Radtke A; Malagó M; Broelsch C
Infection; 2006 Dec; 34(6):328-32. PubMed ID: 17180587
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.
Arathoon EG; Gotuzzo E; Noriega LM; Berman RS; DiNubile MJ; Sable CA
Antimicrob Agents Chemother; 2002 Feb; 46(2):451-7. PubMed ID: 11796357
[TBL] [Abstract][Full Text] [Related]
9. Antifungal alternatives for invasive candidiasis refractory to caspofungin in liver transplant recipients: A report of two cases.
Choukroun G; Thirion M; Lortholary O; Scatton O; Conti F; Calmus Y; Paugam A; Pène F
Transplantation; 2006 Nov; 82(10):1385-6. PubMed ID: 17130792
[No Abstract] [Full Text] [Related]
10. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
11. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
12. Fungal infections in solid organ transplantation.
Marik PE
Expert Opin Pharmacother; 2006 Feb; 7(3):297-305. PubMed ID: 16448324
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
[TBL] [Abstract][Full Text] [Related]
14. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.
Golan Y; Wolf MP; Pauker SG; Wong JB; Hadley S
Ann Intern Med; 2005 Dec; 143(12):857-69. PubMed ID: 16365467
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin--a new therapeutic option for oropharyngeal candidiasis.
Garbino J
Clin Microbiol Infect; 2004 Mar; 10(3):187-9. PubMed ID: 15008939
[TBL] [Abstract][Full Text] [Related]
16. Anidulafungin: a new echinocandin with a novel profile.
Vazquez JA
Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
[TBL] [Abstract][Full Text] [Related]
17. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of caspofungin in solid organ transplant recipients.
Petrovic J; Ngai A; Bradshaw S; Williams-Diaz A; Taylor A; Sable C; Vuocolo S; Kartsonis N
Transplant Proc; 2007 Dec; 39(10):3117-20. PubMed ID: 18089335
[TBL] [Abstract][Full Text] [Related]
19. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin: a review of its use in the treatment of fungal infections.
McCormack PL; Perry CM
Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
